BETA-BLOCKERS increase women’s risk of death and cardiovascular events, according to new study

New research overturns 40 years of heart treatment practice. The REBOOT trial, published in The New England Journal of Medicine and European Heart Journal, found beta-blockers offer no survival benefit for heart attack patients with normal heart function—and may harm women. Women on these drugs had up to 90% higher death risk, likely due to metabolic and physiological differences. Experts now call for personalized, root-cause prevention over outdated, one-size-fits-all prescriptions.

Article